QQ客服 官方微博 反馈留言

	Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial
	Sato, Naoki; Lam, Carolyn S. P.; Teerlink, John R.; Greenberg, Barry H.; Tsutsui, Hiroyuki; Oh, Byung-Hee; Zhang, Jian; Lefkowitz, Martin; Hua, Tsushung A.; Holbro, Thomas
	2017
卷号	23期号:1页码:63-71
关键词	Serelaxin efficacy Asian acute heart failur
ISSN号	1071-9164
DOI	10.1016/j.cardfail.2016.10.016
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6362400
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Sato, Naoki,Lam, Carolyn S. P.,Teerlink, John R.,et al. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial[J],2017,23(1):63-71.
APA	Sato, Naoki.,Lam, Carolyn S. P..,Teerlink, John R..,Greenberg, Barry H..,Tsutsui, Hiroyuki.,...&Ge, Junbo.(2017).Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.,23(1),63-71.
MLA	Sato, Naoki,et al."Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial".23.1(2017):63-71.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。